EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Small Molecule Immunosuppressive Agents in Experimental and Clinical Transplantation

Anlun Ma, Huifang Chen

Current Drug Target -Cardiovascular & Hematological Disorders · 2002

DOI: 10.2174/1568006023337466 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Drug Target -Cardiovascular & Hematological Disorders, 2002. Verfasst von Anlun Ma und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Experimental Surgery, Research Center of CHUM, Notre-Dame Hospital, University of Montreal, 1560 Sherbrooke Street East, Montreal, Queb…. Hauptthemen laut MEDLINE: Transplantation. Die Arbeit wurde bisher 5-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunosuppression is currently the major approach used for the prevention and management of transplant rejection. In this overview, preclinical and clinical studies of the small molecule immunosuppressive agents are reviewed from the discovery of cyclosporine. More recently it was demonstrated that certain agents, namely tacrolimus (FK506), sirolimus (rapamycin), and mycophenolate mofetil (CellCept, MMF), act selectively on adaptive host responses at different stages of T- and B-cell cycles and spare nonspecific host resistance. Because each agent has its specific and significant toxic effects, it has been difficult to optimize the use of individual agents in monotherapy. Therefore, drug combination therapy has been of great interest in addition to the introduction of new small molecule agents, such as malononitrilamides [MNAs (leflunomide, FK778, FK779)], 15-deoxyspergualin (DSG) and its analogues, FTY720 and inhibitors of signal transduction, which offer promising modes of immunosuppression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TransplantationAnimalsGraft RejectionHumansImmunosuppressive Agents

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Laboratory of Experimental Surgery, Research Center of CHUM, Notre-Dame Hospital, University of Montreal, 1560 Sherbrooke Street East, Montreal, Quebec, Canada.

Zitieren

APA

Ma, A., & Chen, H. (2002). Small Molecule Immunosuppressive Agents in Experimental and Clinical Transplantation. Current Drug Target -Cardiovascular & Hematological Disorders. https://doi.org/10.2174/1568006023337466

Vancouver

Ma A, Chen H. Small Molecule Immunosuppressive Agents in Experimental and Clinical Transplantation. Current Drug Target -Cardiovascular & Hematological Disorders. 2002. doi:10.2174/1568006023337466

BibTeX
@article{Ma2002,
  author = {Ma, Anlun and Chen, Huifang},
  title = {Small Molecule Immunosuppressive Agents in Experimental and Clinical Transplantation},
  journal = {Current Drug Target -Cardiovascular & Hematological Disorders},
  year = {2002},
  doi = {10.2174/1568006023337466}
}
Kostenlos starten →